165 related articles for article (PubMed ID: 16357318)
1. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31.
Korff T; Dandekar G; Pfaff D; Füller T; Goettsch W; Morawietz H; Schaffner F; Augustin HG
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):468-74. PubMed ID: 16357318
[TBL] [Abstract][Full Text] [Related]
2. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
3. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
4. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells.
Liu H; Devraj K; Möller K; Liebner S; Hecker M; Korff T
Thromb Haemost; 2014 Jul; 112(1):151-63. PubMed ID: 24522257
[TBL] [Abstract][Full Text] [Related]
5. Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation.
Månsson-Broberg A; Siddiqui AJ; Genander M; Grinnemo KH; Hao X; Andersson AB; Wärdell E; Sylvén C; Corbascio M
Biochem Biophys Res Commun; 2008 Aug; 373(3):355-9. PubMed ID: 18571496
[TBL] [Abstract][Full Text] [Related]
6. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
Shin D; Garcia-Cardena G; Hayashi S; Gerety S; Asahara T; Stavrakis G; Isner J; Folkman J; Gimbrone MA; Anderson DJ
Dev Biol; 2001 Feb; 230(2):139-50. PubMed ID: 11161568
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of endothelial ephrinB2 expression by laminar shear stress.
Goettsch W; Augustin HG; Morawietz H
Endothelium; 2004; 11(5-6):259-65. PubMed ID: 15763946
[TBL] [Abstract][Full Text] [Related]
8. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
Zhang G; Zhou J; Fan Q; Zheng Z; Zhang F; Liu X; Hu S
FEBS Lett; 2008 Aug; 582(19):2957-64. PubMed ID: 18671974
[TBL] [Abstract][Full Text] [Related]
9. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
[TBL] [Abstract][Full Text] [Related]
10. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
11. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
Umeda N; Ozaki H; Hayashi H; Oshima K
Am J Ophthalmol; 2004 Aug; 138(2):270-9. PubMed ID: 15289137
[TBL] [Abstract][Full Text] [Related]
12. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.
Gale NW; Baluk P; Pan L; Kwan M; Holash J; DeChiara TM; McDonald DM; Yancopoulos GD
Dev Biol; 2001 Feb; 230(2):151-60. PubMed ID: 11161569
[TBL] [Abstract][Full Text] [Related]
14. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
16. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
[TBL] [Abstract][Full Text] [Related]
17. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
van den Akker NM; Caolo V; Wisse LJ; Peters PP; Poelmann RE; Carmeliet P; Molin DG; Gittenberger-de Groot AC
Cardiovasc Res; 2008 May; 78(2):366-75. PubMed ID: 18093989
[TBL] [Abstract][Full Text] [Related]
18. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
20. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]